- Home
- MEDP vs DKNG Comparison
MEDP vs DKNG Comparison
Compare MEDP & DKNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MEDP | DKNG |
|---|---|---|
| Founded | 1992 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 11.0B |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MEDP | DKNG |
|---|---|---|
| Price | $422.73 | $26.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 31 |
| Target Price | ★ $473.17 | $38.10 |
| AVG Volume (30 Days) | 449.8K | ★ 10.9M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.98 | ★ 99.05 |
| EPS | ★ 4.28 | 0.03 |
| Revenue | N/A | ★ $6,054,525,000.00 |
| Revenue This Year | $13.19 | $15.47 |
| Revenue Next Year | $7.75 | $13.09 |
| P/E Ratio | $100.52 | ★ N/A |
| Revenue Growth | N/A | ★ 26.99 |
| 52 Week Low | $284.48 | $20.46 |
| 52 Week High | $628.92 | $48.78 |
Technical Indicators
Market Signals| Indicator | MEDP | DKNG |
|---|---|---|
| Relative Strength Index (RSI) | 39.63 | 66.16 |
| Support Level | $382.68 | $25.01 |
| Resistance Level | $477.04 | $26.50 |
| Average True Range (ATR) | 16.56 | 1.00 |
| MACD | -2.21 | 0.32 |
| Stochastic Oscillator | 31.48 | 76.31 |
Price Performance
Historical ComparisonAbout MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About DKNG DraftKings Inc.
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number-two or -three revenue share position across states where it competes. DraftKings is now live with online or retail sports betting in 28 states and i-gaming in 5 states, with both products available to around 40% of Canada's population. In 2024, sports revenue was 61% of total sales, i-gaming 32%, and fantasy and lottery 7%. The company plans to launch a predictive event platform in late 2025 and also operates a non-fungible token commission-based marketplace and develops and licenses online gaming products.